Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B-cell lymphoma
Sharon L. Barrans,
Sheila J. M. O'Connor,
Paul A. S. Evans,
Faith E. Davies,
Roger G. Owen,
Andrew P. Haynes,
Gareth J. Morgan,
Andrew S. Jack,
Sharon L. Barrans
Academic Unit of Haematology and Oncology, HMDS, Algernon Firth Building, Leeds General Infirmary, Leeds, and
Search for more papers by this authorSheila J. M. O'Connor
Academic Unit of Haematology and Oncology, HMDS, Algernon Firth Building, Leeds General Infirmary, Leeds, and
Search for more papers by this authorPaul A. S. Evans
Academic Unit of Haematology and Oncology, HMDS, Algernon Firth Building, Leeds General Infirmary, Leeds, and
Search for more papers by this authorFaith E. Davies
Academic Unit of Haematology and Oncology, HMDS, Algernon Firth Building, Leeds General Infirmary, Leeds, and
Search for more papers by this authorRoger G. Owen
Academic Unit of Haematology and Oncology, HMDS, Algernon Firth Building, Leeds General Infirmary, Leeds, and
Search for more papers by this authorAndrew P. Haynes
Department of Haematology, Nottingham City Hospital, Nottingham, UK
Search for more papers by this authorGareth J. Morgan
Academic Unit of Haematology and Oncology, HMDS, Algernon Firth Building, Leeds General Infirmary, Leeds, and
Search for more papers by this authorAndrew S. Jack
Academic Unit of Haematology and Oncology, HMDS, Algernon Firth Building, Leeds General Infirmary, Leeds, and
Search for more papers by this authorSharon L. Barrans,
Sheila J. M. O'Connor,
Paul A. S. Evans,
Faith E. Davies,
Roger G. Owen,
Andrew P. Haynes,
Gareth J. Morgan,
Andrew S. Jack,
Sharon L. Barrans
Academic Unit of Haematology and Oncology, HMDS, Algernon Firth Building, Leeds General Infirmary, Leeds, and
Search for more papers by this authorSheila J. M. O'Connor
Academic Unit of Haematology and Oncology, HMDS, Algernon Firth Building, Leeds General Infirmary, Leeds, and
Search for more papers by this authorPaul A. S. Evans
Academic Unit of Haematology and Oncology, HMDS, Algernon Firth Building, Leeds General Infirmary, Leeds, and
Search for more papers by this authorFaith E. Davies
Academic Unit of Haematology and Oncology, HMDS, Algernon Firth Building, Leeds General Infirmary, Leeds, and
Search for more papers by this authorRoger G. Owen
Academic Unit of Haematology and Oncology, HMDS, Algernon Firth Building, Leeds General Infirmary, Leeds, and
Search for more papers by this authorAndrew P. Haynes
Department of Haematology, Nottingham City Hospital, Nottingham, UK
Search for more papers by this authorGareth J. Morgan
Academic Unit of Haematology and Oncology, HMDS, Algernon Firth Building, Leeds General Infirmary, Leeds, and
Search for more papers by this authorAndrew S. Jack
Academic Unit of Haematology and Oncology, HMDS, Algernon Firth Building, Leeds General Infirmary, Leeds, and
Search for more papers by this author Sharon L. Barrans, Academic Unit of Haematology and Oncology, HMDS, 1st Floor, Algernon Firth Building, Leeds General Infirmary, Leeds LS1 3EX, UK. E-mail: [email protected]
Abstract
Summary. Diffuse large B-cell lymphomas (DLBCL) are a heterogeneous group of tumours, varying in clinical features, immunophenotype and cytogenetics. The aim of this study was to investigate the prognostic significance of BCL6 gene rearrangement at the 3q27 locus in patients with primary nodal disease, and to examine interrelationships with immunophenotype and International Prognostic Index (IPI). We have developed a fluorescent in situ hybridization (FISH)-based technique for the retrospective analysis of the effect of BCL6 gene rearrangements on survival, using nuclei extracted from paraffin-embedded tissue. FISH results were obtained in 111 presentation cases of nodal DLBCL. The IPI was calculated and each case was stained immunocytochemically for BCL6, BCL2 and CD10. 3q27 rearrangements were detected in 25% of cases. BCL2 protein and a germinal centre (GC) phenotype (defined as CD10+, BCL6+) were expressed in 56% and 41% of cases respectively. In multivariate analysis, rearrangement of 3q27 and BCL2 expression and the absence of a GC phenotype were associated with a poor prognosis. These factors can be used in conjunction with the IPI to improve risk stratification in nodal DLBCL.
References
- Adams, J. (1992) Biotin amplification of biotin horseradish peroxidase signals in histochemical stains. Journal of Histochemistry and Cytochemistry, 40, 1457 – 1463.
- Akasaka, T., Ueda, C., Kurata, M., Akasaka, H., Yamabe, H., Uchiyama, T. & Ohno, H. (2000) Nonimmunoglobulin (non-Ig)/BCL6 gene fusion in diffuse large B-cell lymphoma results in worse prognosis than Ig/BCL6. Blood, 96, 2907 – 2909.
- Alizadeh, A.A., Eisen, M.B., Davis, R.E. Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., YuX., Powell, J.I., Yang, L., Marti, G.E., Moore, T., Hudson, J. Jr, Lu, L., Lewis, D.B., Tibshirani, R., Sherlock, G., Chan, W.C., Greiner, T.C., Weisenburger, D.D., Armitage, J.O., Warnke, R. & Staudt, L.M. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403, 503 – 511.
- Bastard, C., Tilly, H., Lenormand, B., Bigorgne, C., Boulet, D., Kunlin, A., Monconduit, M. & Piguet, H. (1992) Translocations involving band 3q27 and Ig gene regions in non-Hodgkin's lymphoma. Blood, 79, 2527 – 2531.
- Bastard, C., Deweindt, C., Kerckaert, J.P., Lenormand, B., Rossi, A., Pezzella, F., Fruchart, C., Duval, C., Monconduit, M. & Tilly, H. (1994) LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood, 83, 2423 – 2427.
- Butler, M., Corbally, N., Dervan, P.A. & Carney, D.N. (1997a) BCL6 and other genomic alterations in non-Hodgkin's lymphoma (NHL). British Journal of Cancer, 75, 1641 – 1645.
- Butler, M., Chaganti, S., Chaganti, R.S.K. & Dalla-Favera, R. (1997b) Identification of an alternative chromosomal breakpoint site 5′- to the BCL6 locus in diffuse large cell lymphoma. Blood, 90, 316a – 317a.
- Capello, D., Carbone, A., Pastore, C., Gloghini, A., Saglio, G. & Gaidano, G. (1997) Point mutations of the BCL6 gene in Burkitt's lymphoma. British Journal of Haematology, 99, 168 – 170.
- Cattoretti, G., Chang, C.C., Cechova, K., Zhang, J., Ye, B.H., Falini, B., Louie, D.C., Offit, K., Chaganti, R.S. & Dalla-Favera, R. (1995) BCL6 protein is expressed in germinal-center B cells. Blood, 86, 45 – 53.
- Chen, W., Iida, S., Louie, D.C., Dalla-Favera, R. & Chaganti, R.S. (1998) Heterologous promoters fused to BCL6 by chromosomal translocations affecting band 3q27 cause its deregulated expression during B-cell differentiation. Blood, 91, 603 – 607.
- Dalla-Favera, R.YeB.H., Lo Coco, F., Gaidano, G., Lista, F., Knowles, D.M., Louie, D.C., Offit, K. & Chaganti, R.S. (1994) Identification of genetic lesions associated with diffuse large-cell lymphoma. Annals of Oncology, 5, 55 – 60.
- Dierlamm, J., Pittaluga, S., Stul, M., Wlodarska, I., Michaux, L., Thomas, J., Verhoef, G., Verhest, A., Depardieu, C., Cassiman, J.J., De Hagemeijer, A., Wolf-Peeters, C. & Van Den Berghe, H. (1997a) BCL6 gene rearrangements also occur in marginal zone B-cell lymphoma. British Journal of Haematology, 98, 719 – 725.
- Dierlamm, J., Rosenberg, C., Stul, M., Pittaluga, S., Wlodarska, I., Michaux, L., Dehaen, M., Verhoef, G., Thomas, J., De Kelver, W., Bakker-Schut, T., Cassiman, J.J., Raap, A.K., De Wolf-Peeters, C., Van Den Berghe, H. & Hagemeijer, A. (1997b) Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization. Leukemia, 11, 747 – 758.
- Flenghi, L., Ye, B.H., Fizzotti, M., Bigerna, B., Cattoretti, G., Venturi, S., Pacini, R., Pileri, S., Lo Coco, F. & Pescarmona, E. (1995) A specific monoclonal antibody (PG-B6) detects expression of the BCL6 protein in germinal center B cells. American Journal of Pathology, 147, 405 – 411.
- Flenghi, L., Bigerna, B., Fizzotti, M., Venturi, S., Pasqualucci, L., Pileri, S., Ye, B.H., Gambacorta, M., Pacini, R., Baroni, C.D., Pescarmona, E., Anagnostopoulos, I., Stein, H., Asdrubali, G., Martelli, M.F., Pelicci, P.G., Dalla-Favera, R. & Falini, B. (1996) Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL6 protein amino-terminal region. American Journal of Pathology, 148, 1543 – 1555.
- Gaidano, G., Carbone, A., Pastore, C., Capello, D., Migliazza, A., Gloghini, A., Roncella, S., Ferrarini, M., Saglio, G. & Dalla-Favera, R. (1997) Frequent mutation of the 5′ noncoding region of the BCL6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood, 89, 3755 – 3762.
- Galieque Zouitina, S., Quief, S., Hildebrand, M.P., Denis, C., Lecocq, G., Collyn-, D'Hooghe, M., Bastard, C., Yuille, M., Dyer, M.J. & Kerckaert, J.P. (1996) The B cell transcriptional coactivator BOB1/OBF1 gene fuses to the LAZ3/BCL6 gene by t(3;11) (q27;q23.1) chromosomal translocation in a B cell leukemia line (Karpas 231). Leukemia, 10, 579 – 587.
- Gascoyne, R.D., Adomat, S.A., Krajewski, S., Krajewska, M., Horsman, D.E., Tolcher, A.W., O'Reilly, S.E., Hoskins, P., Coldman, A.J., Reed, J.C. & Connors, J.M. (1997) Prognostic significance of BCL2 protein expression and BCL2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood, 90, 244 – 251.
- Heiden, T., Wang, N. & Tribukait, B. (1991) An improved Hedley method for preparation of paraffin-embedded tissues for flow cytometric analysis of ploidy and S-phase. Cytometry, 12, 614 – 621.
- Hill, M.E., MacLennan, K.A., Cunningham, D.C., Vaughan Hudson, B., Burke, M., Clarke, P., Di Stefano, F., Anderson, L., Vaughan Hudson, G., Mason, D., Selby, P. & Linch, D.C. (1996) Prognostic significance of BCL2 expression and BCL2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study. Blood, 88, 1046 – 1051.
- Ichinohasama, R., Miura, I., Funato, T., Sato, I., Suzuki, C., Saito, Y., Decoteau, J.F., Myers, J.B., Kadin, M.E., Sawai, T. & Ooya, K. (1998) A recurrent nonrandom translocation (3;7) (q27;p12) associated with BCL6 gene rearrangement in B-cell diffuse large cell lymphoma. Cancer Genetics and Cytogenetics, 104, 19 – 27.DOI: 10.1016/S0165-4608(97)00412-3
- Kawamata, N., Miki, T., Fukuda, T., Hirosawa, S. & Aoki, N. (1994) The organization of the BCL6 gene. Leukemia, 8, 1327 – 1330.
- Kopf, I., Hanson, C., Delle, U., Verbiene, I. & Weimarck, A. (1996) A rapid and simplified technique for analysis of archival formalin-fixed, paraffin-embedded tissue by fluorescence in situ hybridization (FISH). Anticancer Research, 16, 2533 – 2536.
- Kramer, M.H., Hermans, J., Wijburg, E., Philippo, K., Geelen, E., Van Krieken, J.H., De Jong, D., Maartense, E., Schuuring, E. & Kluin, P.M. (1998) Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood, 92, 3152 – 3162.
- Liang, R., Chan, W.P., Kwong, Y.L., Xu, W.S., Srivastava, G. & Ho, F.C. (1997a) High incidence of BCL6 gene rearrangement in diffuse large B-cell lymphoma of primary gastric origin. Cancer Genetics and Cytogenetics, 97, 114 – 118.
- Liang, R., Chan, W.P., Kwong, Y.L., Chan, A.C., Xu, W.S., Au, W.Y., Srivastava, G. & Ho, F.C. (1997b) BCL6 gene hypermutations in diffuse large B-cell lymphoma of primary gastric origin. British Journal of Haematology, 99, 668 – 670.
- Liang, R., Chan, W.P., Kwong, Y.L., Chan, A.C., Xu, W.S. & Srivastava, G. (1998) Mutation of the 5′ noncoding region of the BCL6 gene in low-grade gastric lymphoma of the mucosa-associated lymphoid tissue. Cancer Genetics and Cytogenetics, 102, 110 – 113.
- Lossos, I.S., Jones, C.D., Warnke, R., Natkunam, Y., Kaizer, H., Zehnder, J.L., Tibshirani, R. & Levy, R. (2001) Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood, 98, 945 – 951.
- Martinka, M., Comeau, T., Foyle, A., Anderson, D. & Greer, W. (1997) Prognostic significance of t(14;18) and BCL2 gene expression in follicular small cleaved cell lymphoma and diffuse large cell lymphoma. Clinical and Investigative Medicine – Medecine Clinique et Experimentale, 20, 364 – 370.
- Migliazza, A., Martinotti, S., Chen, W., Fusco, C.YeB.H., Knowles, D.M., Offit, K., Chaganti, R.S. & Dalla-Favera, R. (1995) Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America, 92, 12520 – 12524.
- Muramatsu, M., Akasaka, T., Kadowaki, N., Ohno, H., Yamabe, H., Edamura, S., Dor, S., Mori, T., Okuma, M. & Fukuhara, S. (1996) Rearrangement of the BCL6 gene in B-cell lymphoid neoplasms: comparison with lymphomas associated with BCL2 rearrangement. British Journal of Haematology, 93, 911 – 920.
- Muramatsu, M., Akasaka, T., Kadowaki, N., Ohno, H., Fukuhara, S. & Okuma, M. (1997) Rearrangement of the BCL6 gene in B-cell lymphoid neoplasms. Leukemia, 11, 318 – 320.
- Niu, H., Pietrafesa, R., Cattoretti, G. & Dalla-Favera, R. (1999) The BCL6 proto-oncogene controls apoptosis in B cells. Blood, 94, 693a.
- Offit, K., Lo Coco, F., Louie, D.C., Parsa, N.Z., Leung, D., Portlock, C., Ye, B.H., Lista, F., Filippa, D.A., Rosenbaum, A., Ladanyi, M., Jhanwar, S., Dalla-Favera, R. & Chaganti, R.S.K. (1994) Rearrangement of the BCL6 gene as a prognostic marker in diffuse large-cell lymphoma. New England Journal of Medicine, 331, 74 – 80.
- Ohno, H. & Fukuhara, S. (1997) Significance of rearrangement of the BCL6 gene in B-cell lymphoid neoplasms. Leukemia and Lymphoma, 27, 53 – 63.
- Ohno, H., Kerckaert, J.P., Bastard, C. & Fukuhara, S. (1994) Heterogeneity in B-cell neoplasms associated with rearrangement of the LAZ3 gene on chromosome band 3q27. Japanese Journal of Cancer Research, 85, 592 – 600.
- Pasqualucci, L., Migliazza, A., Fracchiolla, N., William, C., Neri, A., Baldini, L., Chaganti, R.S., Klein, U., Kuppers, R., Rajewsky, K. & Dalla-Favera, R. (1998) BCL6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proceedings of the National Academy of Sciences of the United States of America, 95, 11816 – 11821.
-
Pescarmona, E.,
De Sanctis, V.,
Pistilli, A.,
Pacchiarotti, A.,
Martelli, M.,
Guglielmi, C.,
Mandelli, F.,
Baroni, C.D. &
Le Coco, F. (1997) Pathogenetic and clinical implications of BCL6 and BCL2 gene configuration in nodal diffuse large B-cell lymphomas.
Journal of Pathology, 183, 281
–
286.
10.1002/(SICI)1096-9896(199711)183:3<281::AID-PATH1134>3.0.CO;2-Z CAS PubMed Web of Science® Google Scholar
- Peng, H.Z., Du, M.Q., Koulis, A., Aiello, A., Dogan, A., Pan, L.X. & Isaacson, P.G. (1999) Nonimmunoglobulin gene hypermutation in germinal center B cells. Blood, 93, 2167 – 2172.
- Sanchez-Izquierdo, D., Siebert, R., Harder, L., Marugan, I., Gozzetti, A., Price, H.P., Gesk, S., Hernandez-Rivas, J.M., Benet, I., Sole, F., Sonoki, T., Le Beau, M.M., Schlegelberger, B., Dyer, M.J., Garcia-Conde, J. & Martinez-Climent, J.A. (2001) Detection of translocations affecting the BCL6 locus in B cell non-Hodgkin's lymphoma by interphase fluorescence in situ hybridization. Leukemia, 15, 1475 – 1484.
- Shipp, M.A., Harrington, D.P., Anderson, J.R., Armitage, J.O., Bonadonna, G., Brittinger, G., Cabanillas, F., Canellos, G.P., Cowan, R.A., Crowther, D., Dahlberg, S., Engelhard, M., Fisher, R.I., Gisselbrecht, C., Lepage, E., Lister, T.A., Meerwaldt, J.H., Montserrat, E., Nissen, N.I., Oken, M.M., Peterson, B.A., Tondini, C., Velasquez, W.A. & Yeap, B.Y. (1993) A predictive model for aggressive non-Hodgkin's lymphoma. New England Journal of Medicine, 329, 987 – 994.
- Ueda, Y., Nishida, K., Miki, T., Horiike, S., Kaneko, H., Yokota, S., Misawa, S., Abe, T., Kashima, K. & Taniwaki, M. (1997) Interphase detection of BCL6/IgH fusion gene in non-Hodgkin lymphoma by fluorescence in situ hybridization. Cancer Genetic and Cytogenetics, 99, 102 – 107.
- Vitolo, U., Gaidano, G., Botto, B., Volpe, G., Audisio, E., Bertini, M., Calvi, R., Freilone, R., Novero, D., Orsucci, L., Pastore, C., Capello, D., Parvis, G., Sacco, C., Zagonel, V., Carbone, A., Mazza, U., Palestro, G., Saglio, G. & Resegotti, L. (1998) Rearrangements of BCL6, BCL2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients. Annals of Oncology, 9, 55 – 61.DOI: 10.1023/A:1008201729596
- Wlodarska, I., Mecucci, C., Stul, M., Michaux, L., Pittaluga, S., Hernandez, J.M., Cassiman, J.J., De Wolf-Peeters, C. & Van den Berghe, H. (1995) Fluorescence in situ hybridization identifies new chromosomal changes involving 3q27 in non-Hodgkin's lymphomas with BCL6/LAZ3 rearrangement. Genes, Chromosomes and Cancer, 14, 1 – 7.
-
Xu, W.S.,
Liang, R.H. &
Srivastava, G. (2000) Identification and characterization of BCL6 translocation partner genes in primary gastric high-grade B-cell lymphoma: heat shock protein 89 alpha is a novel fusion partner gene of BCL6.
Genes, Chromosomes and Cancer, 27, 69
–
75.
10.1002/(SICI)1098-2264(200001)27:1<69::AID-GCC9>3.0.CO;2-5 CAS PubMed Web of Science® Google Scholar
- Yamochi, T., Kaneita, Y., Akiyama, T., Mori, S. & Moriyama, M. (1999) Adenovirus-mediated high expression of BCL-6 in CV-1 cells induces apoptotic cell death accompanied by down-regulation of BCL-2 and BCL-X(L). Oncogene, 18, 487 – 494.
- Ye, B.H., Chaganti, S., Chang, C.C., Niu, H., Corradini, P., Chaganti, R.S. & Dalla-Favera, R. (1995) Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. EMBO Journal, 14, 6209 – 6217.
- Ye, B.H., Cattoretti, G., Shen, Q., Zhang, J., Hawe, N., De Waard, R., Leung, C., Nouri-Shirazi, M., Orazi, A., Chaganti, R.S., Rothman, P., Stall, A.M., Pandolfi, P.P. & Dalla-Favera, R. (1997) The BCL6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nature Genetics, 16, 161 – 170.
- Yoshida, S., Kaneita, Y., Aoki, Y., Seto, M., Mori, S. & Moriyama, M. (1999) Identification of heterologous translocation partner genes fused to the BCL6 gene in diffuse large B-cell lymphomas: 5′-RACE and LA – PCR analyses of biopsy samples. Oncogene, 18, 7994 – 7999.
Citing Literature
